Dr Charlie Widberg is a Commercialisation Manager (Life Sciences) in the Technology Development & Licensing Team where she works to commercialise technologies from across the university.

Prior to joining Cambridge Enterprise, Charlie worked as a Senior Business Development, IP and licensing manager at Research Institutes of Sweden (RISE) and at Umea Universitet Holding, its affiliated incubators and Venture Capital company Norther Light Capital. She has experience commercialising technologies ranging from biotech to diagnostics, MedTech and pharmaceuticals as well as deep tech. Charlie has experience working with IP, strategy and patent portfolio management as well as running an independent consulting business. She has international experience from roles at several top-tier Australian tech transfer organisations and as a post-doc for a spinout developing a novel diabetes/obesity therapeutic.

Charlie holds a Master of Business Administration degree and PhD from the University of Queensland and a bachelor’s degree in Biomedicine from the Karolinska Institute.

Charlie joined Cambridge Enterprise in February 2025.